Shandong Sinoglory Health (603182) - Total Liabilities
Based on the latest financial reports, Shandong Sinoglory Health (603182) has total liabilities worth CN¥260.09 Million CNY (≈ $38.06 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 603182 net asset momentum to track the company's year-over-year net asset growth rate.
Shandong Sinoglory Health - Total Liabilities Trend (2020–2025)
This chart illustrates how Shandong Sinoglory Health's total liabilities have evolved over time, based on quarterly financial data. See 603182 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Shandong Sinoglory Health Competitors by Total Liabilities
The table below lists competitors of Shandong Sinoglory Health ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mirae Asset Venture Investment Co. Ltd
KQ:100790
|
Korea | ₩721.23 Billion |
|
Egetis Therapeutics AB (publ)
ST:EGTX
|
Sweden | Skr299.30 Million |
|
Ningbo Joy Intelligent Logistics Technology Co.Ltd.
SHE:301198
|
China | CN¥202.11 Million |
|
Alico Inc
NASDAQ:ALCO
|
USA | $90.50 Million |
|
Shenzhen Zhongheng Huafa Co Ltd Class A
SHE:000020
|
China | CN¥328.31 Million |
|
Xinjiang West Animal Husbandry
SHE:300106
|
China | CN¥561.20 Million |
|
Hypothekarbank Lenzburg AG
SW:HBLN
|
Switzerland | CHF7.55 Billion |
|
Vindhya Telelinks Limited
NSE:VINDHYATEL
|
India | Rs41.57 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down Shandong Sinoglory Health's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Sinoglory Health (603182) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Sinoglory Health's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Sinoglory Health (2020–2025)
The table below shows the annual total liabilities of Shandong Sinoglory Health from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥269.56 Million ≈ $39.44 Million |
-24.44% |
| 2024-12-31 | CN¥356.76 Million ≈ $52.21 Million |
+39.45% |
| 2023-12-31 | CN¥255.83 Million ≈ $37.44 Million |
+17.51% |
| 2022-12-31 | CN¥217.72 Million ≈ $31.86 Million |
-35.50% |
| 2021-12-31 | CN¥337.56 Million ≈ $49.40 Million |
+39.70% |
| 2020-12-31 | CN¥241.64 Million ≈ $35.36 Million |
-- |
About Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd. manufactures soy proteins in China. The company offers soy protein isolate, concentrate, low-temperature edible soybean meal, soybean oil, and soy dietary fiber products. It also exports its products. The company serves in the United States, the European Union, and Australia. Shandong Sinoglory Health Food Co., Ltd. was founded in 2000 and is based in Liao… Read more